DCOY earnings: real EPS beat/miss history, analyst consensus Buy, P/E -0.16. Updated 2026-07-23.
Decoy Therapeutics (DCOY) Research Hub
Decoy Therapeutics (DCOY) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 2.67 USD (-3.26%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.16, market cap 0.00B. This hub links to the full technical, earnings and options research available for DCOY.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.67 USD (-3.26%) |
| 52-week range | 2.6 USD – 8.33 USD |
| Trend regime | Range |
| 14-day RSI | 16.8 (Oversold) |
| Trailing P/E | -0.16 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
Available research for DCOY
Covered Call on DCOY: how it works, illustrative setup around the real 2.67 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on DCOY: how it works, illustrative setup around the real 2.67 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on DCOY: how it works, illustrative setup around the real 2.67 USD price, max profit/loss, breakeven and when to use it. Educational.
DCOY technical analysis: range, last 2.67 USD, RSI 16.8, 52w range 2.6 USD–8.33 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is DCOY in?
Decoy Therapeutics (DCOY) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is DCOY in an uptrend or downtrend?
As of 2026-09-11, DCOY is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is DCOY's trailing P/E ratio?
DCOY's trailing P/E is -0.16, with a market cap of 0.00B. See the earnings research page for full valuation detail.